Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
3.
5.

Reminders to physicians from an introspective computer medical record. A two-year randomized trial.

McDonald CJ, Hui SL, Smith DM, Tierney WM, Cohen SJ, Weinberger M, McCabe GP.

Ann Intern Med. 1984 Jan;100(1):130-8.

PMID:
6691639
6.
7.

[Systematic recording and computer processing of diabetic data in a metabolism outpatient department].

Leonhartsberger J, Heiser A, Leitgeb H.

Wien Med Wochenschr. 1976 Apr 23;126(16-17):217-9. German. No abstract available.

PMID:
969534
8.

Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.

Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. Erratum in: Clin Ther. 2006 Nov;28(11):1968-9.

PMID:
17157128
9.

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

Diabetes Care. 1998 Apr;21(4):574-9.

PMID:
9571345
10.

Computerized knowledge management in diabetes care.

Balas EA, Krishna S, Kretschmer RA, Cheek TR, Lobach DF, Boren SA.

Med Care. 2004 Jun;42(6):610-21.

PMID:
15167329
11.

Quality of diabetes care in the community: a cross-sectional study in central Israel.

Vinker S, Nakar S, Ram R, Lustman A, Kitai E.

Isr Med Assoc J. 2005 Oct;7(10):643-7.

12.

Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.

Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N.

Diabetes Care. 1996 Dec;19(12):1375-81.

PMID:
8941467
13.
14.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
15.

[Should the occurrence of a first coronary event change the management of diabetes?].

Timsit J, Dubois-Laforgue D.

Arch Mal Coeur Vaiss. 2000 Dec;93 Spec No 4:39-44. Review. French.

PMID:
11296461
16.

Physician response to computer reminders.

McDonald CJ, Wilson GA, McCabe GP Jr.

JAMA. 1980 Oct 3;244(14):1579-81.

PMID:
7420656
17.

[Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].

Schiel R, Müller UA, Stein G.

Med Klin (Munich). 2005 Aug 15;100(8):453-61. German.

PMID:
16096726
18.

Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China.

Palmer JL, Gibbs M, Scheijbeler HW, Kotchie RW, Nielsen S, White J, Valentine WJ.

Adv Ther. 2008 Aug;25(8):752-74. doi: 10.1007/s12325-008-0080-4.

PMID:
18704282
19.

The accuracy of medication data in an outpatient electronic medical record.

Wagner MM, Hogan WR.

J Am Med Inform Assoc. 1996 May-Jun;3(3):234-44.

20.

Supplemental Content

Support Center